Toronto mayor Rob Ford is undergoing rehab at a clinic in GreeneStone Clinic Muskoka, the facility confirmed Friday in a press release.
It's in all the Canadian papers.
Sentiment: Strong Buy
Angel - what is exhibit D -otherwise how do we know how significant it is?
As i said the other day its washed out and can bounce absent news.easy - are you saying you happen to buy all your shares at under 10 cents - kudos.
Btokuno - you can't loose money for that long when you have no cash ...you end up not paying bills and we all know how that ends. - not well. stocks go up on expectations - what do folks expect here? an infusion of cash at these levels?
I haven't gone through the number yet but I think owed money to Mark (on royalties before the merger its there on the books) that gets converted into stock at $1.00 a share when the stock is at 11 cents is good or positive thing. To me that is a no brainer and kudos to Mark in doing a great plus for the balance sheet.
Well, I think there is some buying coming into ARYC because of anticipation of good results with Q1 and positive forward looking statements and updates on the CC.
Angel - what did they say about the recent posts about the 500 pre-IDE? Did they say its complete BS? Anything else you can report or hint at?
cancerdx- its take the ask or offer and "HIT" the bid. That being said the stock appears wash out with the selling abating. I see some tweets on the twitter handle but nothing we haven't heard here before.
didn't say I believe - just saying it wasn't specific. Arrayit has not weighed in on this matter or any of the lawsuits that there is a settlement (it would have to publicly disclose).
As to Arrayit, I look at the record and judge from there that they parse words very carefully and sometimes not even that- take for example november cc where they said that 4th qtr revenues will be up double digits while they ended up down 30%.
easy - you are funny. There are so many lawsuits here. Rumor man wasn't specific and its unlikely to be thae one that was just filed a few weeks ago.
Arycmillionaire - i do remember Mark saying this on the CC. Please note the following is carefully worded.
1. They are manufacturing OvaDx test that will be used for the 500 pre IDE test.
2. They are manufacturing 2,000 of them but they are not clia/iso approved so the value is 0 - IT CAN NEVER BE SOLD EVER. This can never be sold but only used internally for these EARLY TEST (500 OR internal testing that does need clia approved lab- the ARYC is not yet approved).
3. PLEASE NOTICE THE NEXT SENTENCE IS NOT THE DOCRO APPROVED TESTS - but some other patient samples.
4. next sentence refers to DOCRO submitting to FDA - does not mean the samples they started sometime in APRIL.
5. My guess is that end of June quarter is not sanctioned by DOCRO but what they hope to do and what they want us to hear - sorry I am skeptical but they use language purposely and have yet to make a deadline promised.
6. PLEASE HAVE ANGEL, CHABLIS AND YOURSELF CHECK WITH THE COMPANY IF THEY WOULD LIKE TO CLARIFY THIS - PUBLICLY. THERE WAS A REASON FOR NO Q AND A
arycmillionaire - based on some posts and no refutations by company - its debatable whether that is true - doesn't mean it isn't. The company has not announced they are doing the DOCRO supervised test but some other sample I think. There has been questions of money made here so its seems questionable. But if you are correct then it is a good thing. I am just afraid of Avant going into court and asking to halt everything at this point. At least its possible but not sure probable. Actually surprise that they sued before ARYC finished the DOCRO test - they would have much more leverage if they sued afterwards...just waiting for this drama to be over so we can evaluate the potential without lawsuits.
arycmillionaire - I hope you are correct...what do you mean the samples going on right now - not sure if you mean the 500 pre ide samples or something else mentioned on the cc...the only ones that count are the docro supervised test ( which nobody has yet confirmed the company has them)- we need independent verification of results to even get to first base with fda.
Easy - understand your reasoning. I too believe at one point that ARYC would win against Avant - not because breach (there is no contract that they breached) but because a case can be made against Avant for fraud and intention to defraud ARYC from the beginning. But now with the Avant lawsuit and possible injunction - plus ARYC's conflicting statement in 10k and PR over the years - I am not as confidant as I was previously. But you recognize this is all a bet - which I agree but whose outcome is not so easily predicted any longer.
What I would like to see is some definitive progress with OvaDx and the ability to raise enough funds to get there (and not at this very dilutive price if done today). I am now more doubtful about the second than ever before. The company does not inspire confidence in either.
Easy - if you read the docs and especially the technology assignment you will see that there was a simple transaction of IP for 80% stake. The breach of raising money by Avant is meaningful but does not change the unfortunate fact that Rene sign a document that hurt ARYC and its ownership. The outcome will be years from now - the problem is no one will do a partnership, joint venture, or invest/or give money to Arrayit. So what happens next? will there be an injunction against Arrayit going forward? No idea if that sticks too. We are in no man's land and not in a great position. Unfortunately, I get pessimistic day by day on this company and they give no reason to be optimistic (certainly not their tweets). But this is obvious to all that have been paying attention. I wonder what they are telling folks like Angel or Dr-c6 - or they them?
opus - could be. But who thought 30 days ago we would see 10 cents and huge volume. Let us not forget that the private placement stock will be unrestricted in the next 30 or so days. If we had real answers on the company's cash flows and needs over the short term I would feel more comfortable. Right now it looks like things have not progress as predicted on the november cc. Also, I noticed no mention of the backlog in the last cc (or whatever you would call that) - that seems to be deliberate and not good news for 2nd qtr numbers.
btokuno - good pr does not make a company more valuable - good results and credibility of progress is what does. Lately, we are bereft of both. All we need is ovadx to be a success and nothing else. Now with the Avant lawsuit I am no longer sure if anyone will care to buy shares if this company at any price. Jury is out